Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1981;11(Suppl 1):23S–29S. doi: 10.1111/j.1365-2125.1981.tb01835.x

Some considerations on the role of benzodiazepines in the treatment of depression

G B Cassano, L Conti
PMCID: PMC1401637  PMID: 6133530

Abstract

1 Benzodiazepines are regarded as pure anxiolytics, and their value in the treatment of depression is controversial. Nevertheless, symptoms of anxiety and depression coexist in patients with endogenous or neurotic depression, and clinical trials indicate that depressed patients respond better to a benzodiazepine-tricyclic antidepressant combination than to either drug alone.

2 Benzodiazepines may extend tricyclic antidepression efficacy by rapidly relieving anxiety and insomnia. Factor analysis of scores obtained using the Hamilton Depression and Self-Administered Depression Rating Scales confirm the clinical findings by revealing that a close correlation exists among anxiety, insomnia and endogenous depression. The factor analysis data seem to support the wide use of benzodiazepine-tricyclic combinations to treat depressed patients.

Full text

PDF
23S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ayd F. J., Jr Amitriptyline: reappraisal after six years experience. Dis Nerv Syst. 1965 Nov;26(11):719–727. [PubMed] [Google Scholar]
  2. BURT C. G., GORDON W. F., HOLT N. F., HORDERN A. Amitriptyline in depressive states:a controlled trial. J Ment Sci. 1962 Sep;108:711–730. doi: 10.1192/bjp.108.456.711. [DOI] [PubMed] [Google Scholar]
  3. Bowen R. C. The effect of diazepam on the recovery of endogenously depressed patients. J Clin Pharmacol. 1978 May-Jun;18(5-6):280–284. doi: 10.1002/j.1552-4604.1978.tb02447.x. [DOI] [PubMed] [Google Scholar]
  4. Browne M. W. A comparison of two drug treatments in depressive illness. Br J Psychiatry. 1969 Jun;115(523):693–696. doi: 10.1192/bjp.115.523.693. [DOI] [PubMed] [Google Scholar]
  5. Butterworth A. T., Watts R. D. Treatment of hospitalized alcoholics with doxepin and diazepam. A controlled study. Q J Stud Alcohol. 1971 Mar;32(1):78–81. [PubMed] [Google Scholar]
  6. Claghorn J., Kellner R. When is a tranquillizer an antidepressant? Curr Ther Res Clin Exp. 1971 Sep;13(9):575–579. [PubMed] [Google Scholar]
  7. Frommer E. A. Treatment of childhood depression with antidepressant drugs. Br Med J. 1967 Mar 25;1(5542):729–732. doi: 10.1136/bmj.1.5542.729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. GOLD R. L., DRIBBEN I. S. DIAZEPAM THERAPY OF DEPRESSED PATIENTS. J Neuropsychiatr. 1964 Aug;5:366–369. [PubMed] [Google Scholar]
  9. Haider I. A comparative trial of Ro 4-6270 and amitriptyline in depressive illness. Br J Psychiatry. 1967 Sep;113(502):993–998. doi: 10.1192/bjp.113.502.993. [DOI] [PubMed] [Google Scholar]
  10. Hollister L. E. Anxiety, depression and psychotropic drugs. Drugs. 1971;1(3):189–193. doi: 10.2165/00003495-197101030-00001. [DOI] [PubMed] [Google Scholar]
  11. Hollister L. E., Overall J. E., Pokorny A. D., Shelton J. Acetophenazine and diazepam in anxious depressions. Arch Gen Psychiatry. 1971 Mar;24(3):273–278. doi: 10.1001/archpsyc.1971.01750090079012. [DOI] [PubMed] [Google Scholar]
  12. Hollister L. E., Overall J. E. Reflections on the specificity of action of anti-depressants. Psychosomatics. 1965 Sep-Oct;6(5):361–365. doi: 10.1016/s0033-3182(65)72257-3. [DOI] [PubMed] [Google Scholar]
  13. Houck J. E. Combined therapy in anxiety-depressive syndromes. I. Comparative effects of limbitrol (chlordiazepoxide-amitriptyline) and placebo. Dis Nerv Syst. 1970 Apr;31(4):269–273. [PubMed] [Google Scholar]
  14. Houck J. Combined therapy in anxiety-depressive syndromes. II. Comparative effects of amitriptyline and limbitrol (chlordiazepoxide-amitriptyline). Dis Nerv Syst. 1970 Jun;31(6):421–426. [PubMed] [Google Scholar]
  15. Johnson D. A. A double-blind comparison of flupenthixol, nortriptyline and diazepam in neurotic depression. Acta Psychiatr Scand. 1979 Jan;59(1):1–8. doi: 10.1111/j.1600-0447.1979.tb06940.x. [DOI] [PubMed] [Google Scholar]
  16. Johnstone E. E., Claghorn J. L. Doxepin vs. chlordiazepoxide: a controlled comparison in neurotic outpatients. Curr Ther Res Clin Exp. 1968 Oct;10(10):514–519. [PubMed] [Google Scholar]
  17. Kellner R. Chlordiazepoxide in depressive neurosis: an open label cross-over study with amitriptyline. Can Psychiatr Assoc J. 1973 Oct;18(5):393–398. doi: 10.1177/070674377301800508. [DOI] [PubMed] [Google Scholar]
  18. Krakowski A. J. Activity study of doxepin. A new antidepressant. Psychosomatics. 1968 Mar-Apr;9(2):89–95. doi: 10.1016/S0033-3182(68)71880-6. [DOI] [PubMed] [Google Scholar]
  19. Lehmann H. E. Problems of differential diagnosis and choice of therapy in depressive states. Psychosomatics. 1965 Sep-Oct;6(5):266–272. doi: 10.1016/s0033-3182(65)72234-2. [DOI] [PubMed] [Google Scholar]
  20. McDowall A., Owen S., Robin A. A. A controlled comparison of diazepam and amylobarbitone in anxiety states. Br J Psychiatry. 1966 Jun;112(487):629–631. doi: 10.1192/bjp.112.487.629. [DOI] [PubMed] [Google Scholar]
  21. Montgomery B. A., Cullinan T. R., Bayley A. J. A double-blind comparative trial of doxepin hydrochloride and chlordiazepoxide in anxiety and depression in general practice. Br J Clin Pract. 1970 May;24(5):207–209. [PubMed] [Google Scholar]
  22. Poeldinger W. Gli spettri d'azione degli dsicofamaci. Clin Ter. 1968 Jan 31;44(2):103–113. [PubMed] [Google Scholar]
  23. Raskin A., Schulterbrandt J. G., Reatig N., Crook T. H., Odle D. Depression subtypes and response to phenelzine, diazepam, and a placebo. Results of a nine hospital collaborative study. Arch Gen Psychiatry. 1974 Jan;30(1):66–75. doi: 10.1001/archpsyc.1974.01760070050008. [DOI] [PubMed] [Google Scholar]
  24. Ryan H. F., Merrill F. B., Scott G. E., Krebs R., Thompson B. L. Increase in suicidal thoughts and tendencies. Association with diazepam therapy. JAMA. 1968 Mar 25;203(13):1137–1139. [PubMed] [Google Scholar]
  25. SVENSON S. E., GORDON L. E. DIAZEPAM: A PROGRESS REPORT. Curr Ther Res Clin Exp. 1965 Jun;7:367–391. [PubMed] [Google Scholar]
  26. Sarteschi P., Cassano G. B., Castrogiovanni P., Conti L. The use of rating scales for computer analysis of the affective symptoms in old age. Compr Psychiatry. 1973 Jul-Aug;14(4):371–379. doi: 10.1016/0010-440x(73)90030-8. [DOI] [PubMed] [Google Scholar]
  27. Schatzberg A. F., Cole J. O. Benzodiazepines in depressive disorders. Arch Gen Psychiatry. 1978 Nov;35(11):1359–1365. doi: 10.1001/archpsyc.1978.01770350085008. [DOI] [PubMed] [Google Scholar]
  28. Sterlin C., Ban T. A., Jarrold L. The place of doxepin among the anxiolytic-sedative drugs. Curr Ther Res Clin Exp. 1972 Apr;14(4):195–204. [PubMed] [Google Scholar]
  29. Swanson D. A. Benzodiazepines in psychiatry. S Afr Med J. 1975 Oct 18;49(44):1829–1834. [PubMed] [Google Scholar]
  30. VENKOBARAO A. A CONTROLLED TRIAL WITH 'VALIUM' IN OBSESSIVE COMPULSIVE STATE. J Indian Med Assoc. 1964 Jun 16;42:564–567. [PubMed] [Google Scholar]
  31. Weissman M. M., Klerman G. L. The chronic depressive in the community: unrecognized and poorly treated. Compr Psychiatry. 1977 Nov-Dec;18(6):523–532. doi: 10.1016/s0010-440x(97)90002-x. [DOI] [PubMed] [Google Scholar]
  32. Woodward J. A., Henry B. W., Overall J. E. Patterns of symptom change in anxious depressed outpatients treated with different drugs. Dis Nerv Syst. 1975 Mar;36(3):125–129. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES